Stephane Wolf

For anyone looking to improve their questioning techniques, "The Art of Asking Smarter Questions" from Harvard Business Review is a must-read. This article delves into how asking the right questions can drive better decision-making, foster innovation, and enhance problem-solving. It provides practical strategies for refining your inquiry skills, which are essential for leaders and teams aiming to achieve greater clarity and insight. Read it to learn how to transform your approach to questioning and unlock deeper understanding and creativity in your work. Enjoy!

9

1 Kommentar

In this 🆕 new era of AI-human collaboration, most of us will need one or more of what we call “fusion skills”, Since the #AI revolution isn’t coming; it’s already here, Some of these skills are 👍Intelligent interrogation (skill of thinking with AI), 👍 Judgment integration (ability to make human-machine interactions more trustworthy), 👍 Reciprocal apprenticing (the skill of tailoring gen AI as per your specific needs). Several techniques are highlighted in this article to improve these essential skills which helps in improving the accuracy of results. #Happyreading #weekend #genAI

19

2 Kommentare

There is probably a universe of opportunities behind AI but also a number of potential side effects coming along with it. One of the more meaningful one‘s might be errosion of leadership quality from individuals hiding their responsibility for decisions taken behind data and algorithms.

5

How Much Time Should We Spend on Strategy? One of the most common questions we at WhiteSpace Consulting & Capability Building get asked during our Brand Fitness Gym workshops or by our clients is, "How much time should we spend on strategy?" Our response is that it depends on the situation—there's no one-size-fits-all answer to this question. To explore this further, I drew a parallel from my training for running marathons, which offers valuable insights. Preparing for a marathon involves four  key components: -   Strength  -   Nutrition  -   Stamina -  Rest In a business context, these can be translated into: -   Strength = Strategy -   Nutrition = Capability building -   Stamina = Execution  -  Rest = Reflection and insight gathering  Strength (Strategy):  This is about building core competencies, much like strengthening the muscles in your legs, calves, and upper body for a marathon.  Nutrition (Capability building):  Just as nutrition fuels your body, Capability of the team builds your business  Stamina (Execution):  Actually running on the road builds your stamina and endurance, similar to executing your business plans. Rest (Reflection and insight gathering)- An essential part of training. A balance is a must Now, how much time should be spent on each of these areas? Below is a typical breakdown of time spent during a 4-6 month marathon training period: -   Strength (Strategy):                23% of the time -   Stamina (Execution):           56% of the time -   Rest:                                            22% of the time Interestingly, in business, we often suffer from "Action Bias," where we feel that if we're not constantly doing something, we might become redundant. However, focusing solely on execution without enough strategic planning can lead to burnout or misguided efforts. STRENGTH TRAINING (STRATEGY) Let’s zoom in on strength-building (strategy). A typical strength session lasts anywhere from 45 to 75 minutes, but not all of that time is spent on actual strength training. A typical session has three parts: 1. Warmup 2. Exercises 3. Cool down The key takeaway here is the quality of time spent. Even though we might allocate 23% of our time to strength training, only about 60% of that time (14% of the total time) is spent on actual strengthening. In business, this means that it’s not just about how much time you spend on strategy, but how effectively you use that time.  Conclusion: What’s important is not just the time you spend on strategy but the quality and focus of that time. Just as in marathon training, where balanced preparation is key to success, in business, a thoughtful balance of strategy, execution, and rest is crucial to achieving your goals. What is your take on how much time should a business or a brand spend of strategy?

37

3 Kommentare

Check out AUX-001 Phase 1a results presented at European Society of Cardiology annual meeting in London by Uwe Tigör, MD, our Chief Medical Officer at Auxilius Pharma. Phase 1a study explored the safety, tolerability, and pharmacokinetics of our compound, which is promising new medication for chronic stable angina. Now that the meeting’s embargo has lifted, we’re thrilled to share these results with you! Check out the attached presentation for more details. If you’d like the full version of the deck, feel free to reach out directly to @Uwe Tigör, MD or to me #cardiology #CSAP #AUX001 #ESC #newmedication #biotech #news

48

Ever wondered why the "Warrens of the world" get promoted? Why everyone sounds like everyone else all of a sudden? Why every other post reads the exact same on LinkedIn? Why people commenting on your posts are using the same commentary in the comments (they maybe bots, and no you should not connect) Why essentially an AI tool can make you sound like the business even if you are licking envelopes for a living? PS: I am not judging, I have done that job in med comms when sending out 100s of HCP packs, we had a wet stamp pad, remember those? Warren IQ - Questionable EQ - Close to Zero Apple Intelligence - is undoubtedly smarter than the average Warren bear. Yes its very similar to plenty of things like Grammarly, MS Editor, Hemmingway etc... but it's in your phone now! What's the excuse now not to sound all professional huh? Another great bit of Ad storytelling by Apple. https://lnkd.in/ez3cNt75 Content that Connects ❤️ #ai #content

2

👉Interested in #socialmedia in the #MultipleSclerosis space? 👉Check out our #ECTRIMS2024 #socialmedia report! 📥 http://dlvr.it/TG50D2 🚀 Our team monitored and analyzed ECTRIMS-related posts on X (previously #Twitter) before, during, and after the event. Here are some key takeaways: 🔍 Key hashtags: The conversation spotlighted #NMOSD, #MOGAD, #Immunic, and #Tolebrutinib as major areas of focus. 🧠Hashtags like #RMS, #Vidoflumidus, and patient-related topics also gained notable attention. Top Discussion Themes: #Data led discussions 📊, accounting for 18% of the conversation. #Efficacy 💯 followed at 12.5%, and #ClinicalTrials 🔬 at 11.4%. Themes like #Education 🧑‍🏫, #PatientPerspectives 🧍, and #Diagnostics 🩺 made up smaller shares at 8%, 6.6%, and 6%, respectively. Leading Voices: Posts originating from #Education-related accounts were the most prominent 🎤, contributing 40% of the conversation. Posts from #Physicians 🩺, #Researchers 🔬, and #Media 📰 users each accounted for 20%. There were no top-performing posts from Nurses, Companies, or Advocate accounts on the X platform. Audience #Sentiment: The overall sentiment was positive 😄, with 70% of social media posts radiating enthusiasm for groundbreaking research and robust community interactions. 20% conveyed neutral updates on event logistics and informative sessions, while 10% expressed concerns over hurdles faced in clinical trials and accessibility of treatments. Text Analytics: New treatments, data-driven decisions, and patient-centered approaches took center stage. Discussions highlighted the role of biomarkers and DMTs like #Tolebrutinib. Beyond #MS, conditions like #NMOSD and #MOGAD also gained focus. 👉 If you are interested in #socialmedia coverage during conferences, send us a message at [email protected]; we cover multiple #therapyareas and events! Americas Committee for Treatment & Research in Multiple Sclerosis (ACTRIMS) Alexion Pharmaceuticals, Inc. Amgen Biogen Bristol Myers Squibb Chugai Pharma Europe EMSP - European Multiple Sclerosis Platform Gilead Sciences Roche icometrix Fujirebio Johnson & Johnson JuneBrain Inc. Kyverna Therapeutics Merck Group MS Data Alliance Novartis Quanterix Sandoz Sanofi Shift.ms SYSNAV Healthcare Takeda Teva Pharmaceuticals TG Therapeutics, Inc. Neuraxpharm UCB ViewMind Inc. #HealthcareConsulting #ECTRIMS24 #SocialListening #DigitalHealth #Neurology #MedicalEducation #LucidQuest #CompetitiveMarketing

1

Interested in #socialmedia in the #dermatology space? Check out our #EADV2024 report! 📥 Download here: http://dlvr.it/TFzJDH 🚀 Our team monitored and analyzed EADV-related posts on X (previously #Twitter) before, during, and after the event. Here are some key takeaways: 🔍 Key Hashtags: The conversation spotlighted #psoriasis and #atopicdermatitis as major areas of focus. 🩺 Hashtags like #HS, #PsoriaticArthritis, #AlopeciaAreata, and those related to #MedicalSkincareBrands also gained significant attention. Top Discussion Themes: #Data led discussions 📊, accounting for approximately 21.8% of the conversation. #Efficacy 💯 and #ClinicalTrials 🔬 followed at ~15% and ~11.4%, respectively. Leading Voices: Posts originating from #Physicians 🩺, #Education-related accounts 🧑‍🏫, and #Media 📰 each accounted for 28.67% of the leading voices. #Researchers 🔬 contributed 14%. Advocates, Nurses, and Companies were virtually absent from top-performing posts. Audience #Sentiment: The overall sentiment was positive 😄, with approximately 75% of posts welcoming new research, innovation in diagnostics, optimism for patient care, and knowledge exchange. Negative sentiment was minimal at ~5%, focusing on research gaps and clinical practice challenges, while ~20% of posts were neutral and informative. Text Analytics: #EADV2024 was heavily focused on #AtopicDermatitis, #Psoriasis, and #PlaquePsoriasis. The role of imaging 🖼️ was extensively discussed, particularly in the context of diagnosing skin diseases and educating attendees. 👉 If you are interested in #socialmedia coverage during conferences, send us a message at [email protected]; we cover multiple #therapyareas and events! #HealthcareConsulting #EADV2024 #SocialListening #DigitalHealth #Dermatology #MedicalEducation #LucidQuest #CompetitiveMarketing

1

The recent McKinsey report reveals a soaring AI adoption rate, with 65% of organizations now utilizing generative AI. This increase underscores AI's impact on reducing costs and driving revenue, particularly in marketing, sales, and product development. Despite challenges like accuracy and IP concerns, high performers effectively overcome these obstacles by integrating AI more extensively across functions. Exciting times lie ahead as we witness AI's transformative potential in the industry! You can read more here: The State of AI in Early 2024 (https://lnkd.in/dRnwfwu4). #AI #GenAI #DigitalTransformation #Innovation #Technology

34

Reflecting on a year of change and growth, I've realized that embracing new challenges is not just about adapting, but about thriving. Moving from Zurich to Boston has taught me that change, in all its glory, is a powerful teacher. It’s fascinating how subtle communication preferences and norms shape our experiences and interactions. Here's to more learning and evolving. #Boston #Zurich #Growth #ShiftPerspective #crossculturalcommunication

77

5 Kommentare

Brands need to provide content experiences and build digital strategies outside a website. The premise of bringing people to a website or via a page-based web-building foundation using a traditional content management system is now obsolete. On the other hand, a DXP built on monolithic architecture will not deliver all the benefits of a fully composable platform. A composable digital experience platform (DXP) can help marketers; 1) Maintain a responsive presence across digital channels and devices from one central hub by seamlessly and rapidly optimizing and pushing out marketing campaigns to reach customers where they are 2) Manage, integrate, and deliver content across every digital channel. 3) Deliver digital experiences, not web pages - focused on journeys rather than interactions 4) Deliver content and experiences across different channels 5) Deliver personalized digital experiences at scale in real-time #composable #martech #content #web #multichannel #digitalexperiences #marketing #digitalmarketing #marketingtechnology

11

👉Interested in #socialmedia in the #MultipleSclerosis space? 👉Check out our #ECTRIMS2024 #socialmedia report! 📥 http://dlvr.it/TGJcfw 🚀 Our team monitored and analyzed ECTRIMS-related posts on X (previously #Twitter) before, during, and after the event. Here are some key takeaways: 🔍 Key hashtags: The conversation spotlighted #NMOSD, #MOGAD, #Immunic, and #Tolebrutinib as major areas of focus. 🧠Hashtags like #RMS, #Vidoflumidus, and patient-related topics also gained notable attention. Top Discussion Themes: #Data led discussions 📊, accounting for 18% of the conversation. #Efficacy 💯 followed at 12.5%, and #ClinicalTrials 🔬 at 11.4%. Themes like #Education 🧑‍🏫, #PatientPerspectives 🧍, and #Diagnostics 🩺 made up smaller shares at 8%, 6.6%, and 6%, respectively. Leading Voices: Posts originating from #Education-related accounts were the most prominent 🎤, contributing 40% of the conversation. Posts from #Physicians 🩺, #Researchers 🔬, and #Media 📰 users each accounted for 20%. There were no top-performing posts from Nurses, Companies, or Advocate accounts on the X platform. Audience #Sentiment: The overall sentiment was positive 😄, with 70% of social media posts radiating enthusiasm for groundbreaking research and robust community interactions. 20% conveyed neutral updates on event logistics and informative sessions, while 10% expressed concerns over hurdles faced in clinical trials and accessibility of treatments. Text Analytics: New treatments, data-driven decisions, and patient-centered approaches took center stage. Discussions highlighted the role of biomarkers and DMTs like #Tolebrutinib. Beyond #MS, conditions like #NMOSD and #MOGAD also gained focus. 👉 If you are interested in #socialmedia coverage during conferences, send us a message at [email protected]; we cover multiple #therapyareas and events! Americas Committee for Treatment & Research in Multiple Sclerosis (ACTRIMS) Alexion Pharmaceuticals, Inc. Amgen Biogen Bristol Myers Squibb Chugai Pharma Europe EMSP - European Multiple Sclerosis Platform Gilead Sciences Roche icometrix Fujirebio Johnson & Johnson JuneBrain Inc. Kyverna Therapeutics Merck Group MS Data Alliance Novartis Quanterix Sandoz Sanofi Shift.ms SYSNAV Healthcare Takeda Teva Pharmaceuticals TG Therapeutics, Inc. Neuraxpharm UCB ViewMind Inc. #HealthcareConsulting #ECTRIMS24 #SocialListening #DigitalHealth #Neurology #MedicalEducation #LucidQuest #CompetitiveMarketing

1

Comprehensive McKinsey & Company report on #Generative #AI in #healthcare: Adoption trends and what’s next. As an ever-evolving field, the hot topic of AI has huge potential applications in healthcare. It's interesting to discuss how fast and how far it will go. An insightful read. #healthcaretechnology #trends2024

6

Can’t be more agree, than Omnichannel becomes critical when you are in a competitive environment, and you need to sell more than your competition. But when you have a truly revolutionary product, you don’t need to engage in sophisticated omnichannel approaches to commercialise it. It seems to me that the argument about helping patients and physicians is always above and trying to mute that of selling. But selling is a noble activity and nothing to be ashamed of. It’s true that the industry needs to support healthcare professionals on recommending the right medicines for the right patients but also needs to sell and generate a profit that could then be invested into more innovation or further access to medicines.

7